Zentek (CVE:ZEN) Trading 10.3% Higher – Still a Buy?
by Scott Moore · The Cerbat GemZentek Ltd. (CVE:ZEN – Get Free Report)’s stock price shot up 10.3% during trading on Wednesday . The stock traded as high as C$0.63 and last traded at C$0.59. Approximately 204,948 shares traded hands during mid-day trading, an increase of 44% from the average daily volume of 142,211 shares. The stock had previously closed at C$0.54.
Zentek Price Performance
The company has a current ratio of 1.00, a quick ratio of 7.59 and a debt-to-equity ratio of 15.41. The firm’s 50-day moving average price is C$0.76 and its two-hundred day moving average price is C$0.87. The stock has a market cap of C$74.07 million, a PE ratio of -7.37 and a beta of 0.52.
Zentek Company Profile
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.